148 related articles for article (PubMed ID: 22415136)
1. Overexpression of IL-7 enhances cisplatin resistance in glioma.
Cui L; Fu J; Pang JC; Qiu ZK; Liu XM; Chen FR; Shi HL; Ng HK; Chen ZP
Cancer Biol Ther; 2012 May; 13(7):496-503. PubMed ID: 22415136
[TBL] [Abstract][Full Text] [Related]
2. The effects of wild-type p53 gene transfection on the growth and chemotherapeutic sensitivity of human glioma cells.
Xiang W; Zhu X; Zhao H
J Huazhong Univ Sci Technolog Med Sci; 2002; 22(1):44-6. PubMed ID: 12658781
[TBL] [Abstract][Full Text] [Related]
3. Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human glioblastoma cells.
Hong Y; Shang C; Xue YX; Liu YH
Med Sci Monit; 2015 Apr; 21():1002-7. PubMed ID: 25858624
[TBL] [Abstract][Full Text] [Related]
4. LRIG1 enhances cisplatin sensitivity of glioma cell lines.
Wang X; Xiao Q; Xing X; Tian C; Zhang H; Ye F; Wan F; Wang B; Guo D; Lei T
Oncol Res; 2012; 20(5-6):205-11. PubMed ID: 23581227
[TBL] [Abstract][Full Text] [Related]
5. The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell Lines.
Wang Q; Wang Z; Chu L; Li X; Kan P; Xin X; Zhu Y; Yang P
PLoS One; 2015; 10(5):e0125473. PubMed ID: 25950430
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity.
Su PF; Song SQ
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6864-6872. PubMed ID: 30402851
[TBL] [Abstract][Full Text] [Related]
7. Is mda-7/IL-24 a potential target and biomarker for enhancing drug sensitivity in human glioma U87 cell line?
Wang Q; Zhu Y; Yang P
Anat Rec (Hoboken); 2013 Aug; 296(8):1154-60. PubMed ID: 23794295
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl‑2 pathway.
Qian C; Li P; Yan W; Shi L; Zhang J; Wang Y; Liu H; You Y
Mol Med Rep; 2015 Mar; 11(3):1951-5. PubMed ID: 25405848
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro.
Chen J; Sun X; Yang W; Jiang G; Li X
Tumour Biol; 2010 Dec; 31(6):613-22. PubMed ID: 20623264
[TBL] [Abstract][Full Text] [Related]
10. Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway.
Cao WQ; Zhai XQ; Ma JW; Fu XQ; Zhao BS; Zhang P; Fu XY
Pharm Biol; 2020 Dec; 58(1):72-79. PubMed ID: 31875760
[No Abstract] [Full Text] [Related]
11. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
[TBL] [Abstract][Full Text] [Related]
12. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
[TBL] [Abstract][Full Text] [Related]
13. PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway.
Li H; Zhang X; Song X; Zhu F; Wang Q; Guo C; Liu C; Shi Y; Ma C; Wang X; Zhang L
Cancer Biol Ther; 2012 Jul; 13(9):822-30. PubMed ID: 22688731
[TBL] [Abstract][Full Text] [Related]
14. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
Liu HJ; Li GL; Lei PC
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
[No Abstract] [Full Text] [Related]
15. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
16. C
He XY; Xiong LL; Xia QJ; Wang YY; Zhao XM; Du RL; Huang J; He XQ; Jia-Liu ; Wang TH
Biomed Res Int; 2019; 2019():6821219. PubMed ID: 30915356
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
18. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
19. MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.
Chen X; Zhang Y; Shi Y; Lian H; Tu H; Han S; Peng B; Liu W; He X
Int J Oncol; 2015 Oct; 47(4):1603-11. PubMed ID: 26323558
[TBL] [Abstract][Full Text] [Related]
20. [Adenovirus mediated IL-24 gene expression inhibits growth of human glioma cell in vitro].
Shan Y; Sheng W; Xie Y; Liu T; Jing Y; Hu Z; Yang J
Sheng Wu Gong Cheng Xue Bao; 2009 Feb; 25(2):279-86. PubMed ID: 19459336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]